Summary
SIS TriTren 150, manufactured by SIS Labs, was independently tested to verify its composition, dosing accuracy, and sterility. The sample, funded and submitted by AnabolicLab, contained two active Trenbolone esters: Trenbolone Acetate and Trenbolone Enanthate. However, the third ester, Trenbolone Hexahydrobenzylcarbonate, was not detected. The analysis revealed measured concentrations of 74.6 mg/ml for Trenbolone Acetate and 74.1 mg/ml for Trenbolone Enanthate, which exceeded their respective label claims. No microbiological contamination was detected.
The sample was identified by batch number 001-30580, received on 1 December 2017, and analyzed by SIMEC AG, a renowned laboratory specializing in pharmaceutical quality control. These findings highlight discrepancies in the product’s composition, underscoring the importance of ongoing third-party testing to validate quality and ensure harm reduction.
Detailed Report
Product Overview
- Manufacturer: SIS Labs
- Product Name: TriTren 150
- Batch Number: 001-30580
- Expiration Date: January 2020
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: C64169
- Date Purchased: Not specified
- Product Submitted By: AnabolicLab
- Analysis Paid For By: AnabolicLab
- Analysis Performed By: SIMEC AG
- Date Received by Lab: 1 December 2017
- Date Testing Conducted: 17 January 2018
Testing Results
| Compound | Measured Concentration | Label Claim | Accuracy | Variance |
|---|---|---|---|---|
| Trenbolone Acetate | 74.6 mg/ml | 60 mg/ml | 124.33% | +24.33% |
| Trenbolone Enanthate | 74.1 mg/ml | 50 mg/ml | 148.20% | +48.20% |
| Trenbolone Hexahydrobenzylcarbonate | Not detected | 40 mg/ml | 0.00% | -100% |
Microbiological Testing
- Total Aerobial Microbiological Count (TAMC): <1 CFU/ml (No contamination detected)
- Total Yeast and Mold Count (TYMC): <1 CFU/ml (No contamination detected)
Verification Details
- Verification URL: Not provided in the report
- Originally Published: Not available
Evaluation of Testing Results
The analysis of SIS TriTren 150 revealed significant deviations in its composition. While Trenbolone Acetate and Trenbolone Enanthate exceeded their label claims, Trenbolone Hexahydrobenzylcarbonate was completely absent from the formulation. These findings suggest potential issues in the manufacturing process or misrepresentation of the product’s composition. The sterility of the sample was confirmed, with no detectable microbial contamination.
Since the sample was submitted and funded by AnabolicLab, the testing results provide valuable insights into the product’s quality. However, independent market-sourced testing across multiple batches is recommended to verify consistency and ensure consumer safety.
Conclusion
The independent analysis of SIS TriTren 150 by SIMEC AG highlights discrepancies in the product’s composition. While the sterility and measured concentrations of two Trenbolone esters were verified, the absence of Trenbolone Hexahydrobenzylcarbonate indicates a critical issue. These findings underscore the importance of ongoing third-party validation to ensure accurate dosing and consistent product quality. This report aims to support transparency and promote harm reduction in the anabolic steroid market.
Disclaimer
This report is published for educational and harm reduction purposes. While the findings pertain solely to the tested batch, discrepancies in manufacturer claims emphasize the need for further independent testing. Readers are encouraged to use this information responsibly and cross-reference with additional third-party analyses for comprehensive validation.
Discuss the SIS Laboratories Tri-Tren 150 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)
